4.6 Article

Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Treated with Hyaluronic Acid

期刊

PLOS ONE
卷 9, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0091609

关键词

-

向作者/读者索取更多资源

Aims: To investigate urinary nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in interstitial cystitis/bladder pain syndrome (IC/BPS) patients after hyaluronic acid (HA) therapy. Methods: Thirty-three patients with IC/BPS were prospectively studied; a group of 45 age-matched healthy subjects served as controls. All IC/BPS patients received nine intravesical HA instillations during the 6-month treatment regimen. Urine samples were collected for measuring urinary NGF and BDNF levels at baseline and 2 weeks after the last HA treatment. The clinical parameters including visual analog scale (VAS) of pain, daily frequency nocturia episodes, functional bladder capacity (FBC) and global response assessment (GRA) were recorded. Urinary NGF and BDNF levels were compared between IC/BPS patients and controls at baseline and after HA treatment. Results: Urinary NGF, NGF/Cr, BDNF, and BDNF/Cr levels were significantly higher in IC/BPS patients compared to controls. Both NGF and NGF/Cr levels significantly decreased after HA treatment. Urinary NGF and NGF/Cr levels significantly decreased in the responders with a VAS pain reduction by 2 (both p < 0.05) and the GRA improved by 2 (both p < 0.05), but not in non-responders. Urinary BDNF and BDNF/Cr did not decrease in responders or non-responders after HA therapy. Conclusions: Urinary NGF, but not BDNF, levels decreased significantly after HA therapy; both of these factors remained higher than in controls even after HA treatment. HA had a beneficial effect on IC/BPS, but it was limited. The reduction of urinary NGF levels was significant in responders, with a reduction of pain and improved GRA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study

Yung Tai Chen, Hsin-Chih Yeh, Hsiang-Ying Lee, Po-Fan Hsieh, Eric Chieh-lung Chou, Yao-Chou Tsai, Jian-Hua Hong, Chao-Yuan Huang, Yuan-Hong Jiang, Yu-Khun Lee, Jen-Shu Tseng, Chih-Chin Yu, Bing-Juin Chiang, Thomas Y. Hsueh, Chia-Chang Wu, Chung-You Tsai

Summary: This study retrospectively reviewed the treatment outcomes of endoscopic management for clinically localized UTUC in Taiwan, and found that endoscopic treatment is safe and effective in this area. Early salvage radical nephroureterectomy (RNU) is necessary for UTUC refractory to endoscopic management in order to prevent UTUC-related mortality.

ASIAN JOURNAL OF SURGERY (2023)

Article Biochemistry & Molecular Biology

Sensory Receptor, Inflammatory, and Apoptotic Protein Expression in the Bladder Urothelium of Patients with Different Subtypes of Interstitial Cystitis/Bladder Pain Syndrome

Yuan-Hong Jiang, Jia-Fong Jhang, Lori A. A. Birder, Hann-Chorng Kuo

Summary: The aim of this study was to investigate the expression levels of sensory receptors, inflammatory proteins, and pro-apoptotic proteins in the urothelium of non-Hunner's interstitial cystitis (NHIC) bladders of patients with different clinical and cystoscopic phenotypes. The study concluded that IC/BPS patients with frequency and bladder pain complaints have higher levels of urothelial sensory receptors, and inflammatory and pro-apoptotic proteins. The expression levels of these sensory receptors, inflammatory proteins, and pro-apoptotic proteins are not significantly different among IC/BPS bladders with different conditions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion

Jia-Fong Jhang, Cheng-Der Liu, Yung-Hsiang Hsu, Chien-Chin Chen, Hsiang-Chin Chen, Yuan-Hong Jiang, Wan-Chen Wu, Chih-Wen Peng, Hann-Chorng Kuo

Summary: In this study, EBV persistence and reactivation were detected in the B cells of HIC bladders, suggesting the involvement of EBV infection in bladder inflammation. Nerve hyperplasia and upregulation of BDNF were also observed in HIC bladders, with the origin of BDNF found to be EBV-infected B cells. Knockdown of BDNF in EBV-infected B cells inhibited cell proliferation and viability, while implantation of BDNF-depleted EBV-infected B cells abrogated tissue inflammation and nerve hyperplasia, providing insights into the mechanisms underlying the involvement of EBV-infected B cells in HIC pathogenesis.

JOURNAL OF PATHOLOGY (2023)

Article Biochemistry & Molecular Biology

Urinary Oxidative Stress Biomarkers in the Diagnosis of Detrusor Overactivity in Female Patients with Stress Urinary Incontinence

Wei-Hsin Chen, Yuan-Hong Jiang, Hann-Chorng Kuo

Summary: Urinary oxidative stress biomarkers can be used to diagnose and predict the occurrence of detrusor overactivity (DO) in women with urodynamic stress incontinence (USI). Combined with voided volume, the diagnostic accuracy can be improved.

BIOMEDICINES (2023)

Review Medicine, General & Internal

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis

Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo

Summary: Botulinum toxin A (BoNT-A) has been widely used in urological functional disorders such as neurogenic detrusor overactivity (NDO), overactive bladder (OAB), lower urinary tract dysfunction, and interstitial cystitis/bladder pain syndrome (IC/BPS). The chronic inflammation in OAB and IC/BPS can be reduced by inhibiting sensory peptides with BoNT-A, leading to symptom improvement. Although not approved by FDA for IC/BPS, intravesical BoNT-A injection is recommended as the fourth line therapy. Experimental trials are being conducted to explore alternative delivery methods and minimize adverse events. This article reviews the current research on BoNT-A in OAB and IC/BPS.

TZU CHI MEDICAL JOURNAL (2023)

Article Multidisciplinary Sciences

Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy

Wei-Hsin Chen, Yu Khun Lee, Hann-Chorng Kuo, Jen-Hung Wang, Yuan-Hong Jiang

Summary: This study examined the outcomes of robot-assisted radical prostatectomy (RaRP) in high-risk and very high-risk prostate cancer patients. The results showed that high-risk/very high-risk patients without adjuvant treatment had worse biochemical recurrence-free survival compared to those with adjuvant treatment. However, the combination of RaRP and adjuvant treatment resulted in comparable biochemical recurrence-free survival for high-risk/very high-risk patients and below high-risk patients. Additionally, high-risk/very high-risk patients had higher rates of stress urinary incontinence at postoperative week 1 and month 1 compared to below high-risk patients, but there was no significant difference in incontinence rates between the two groups from postoperative 3 months to 12 months.

PLOS ONE (2023)

Article Biochemistry & Molecular Biology

Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome

Jia-Fong Jhang, Yuan-Hong Jiang, Hann-Chorng Kuo

Summary: This study investigated the role of urinary biomarkers in discriminating different bladder and bladder outlet dysfunctions in women with frequency-urgency syndrome. The results showed that there were significant variations in the urinary levels of inflammatory, neurogenic, and oxidative stress biomarkers among patients with different urodynamic subtypes. These findings suggest that the presence of varying bladder inflammation and oxidative stress conditions may have an impact on treatment outcomes in women with frequency-urgency syndrome.

BIOMEDICINES (2023)

Review Medicine, Research & Experimental

Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications

Siyu Wu, Rong Li, Yuanhong Jiang, Jiazheng Yu, Jianyi Zheng, Zeyu Li, Mingyang Li, Kerong Xin, Yang Wang, Zhenqun Xu, Shijie Li, Xiaonan Chen

Summary: Liquid biopsy is an accurate method for determining molecular profiles in urothelial carcinoma (UC). It has the potential to play a crucial role in early diagnosis, treatment monitoring, and prognosis prediction, thereby contributing to precision medicine in UC management.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Pharmacology & Pharmacy

Current optimal pharmacologic therapies for overactive bladder

Yuan-Hong Jiang, Hann-Chorng Kuo

Summary: This review summarizes the recent results of clinical trials and studies on medication for OAB and explores the underlying pathophysiology of OAB. Antimuscarinic agents and beta-3 adrenoceptor agonists are feasible as first-line treatments. Combination therapy can improve therapeutic efficacy for patients who do not respond well to full-dose antimuscarinics or mirabegron. Intravesical BoNT-A injection is effective for refractory OAB. For patients who do not respond to initial pharmacotherapies, investigating the underlying pathophysiology and adding appropriate medications, such as alpha 1-blockers or anti-inflammatory agents, is recommended. Patient education on behavioral modifications and therapies should always be provided.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Article Biochemistry & Molecular Biology

Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions

Wan-Ru Yu, Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo

Summary: This study aimed to analyze urinary biomarkers in men with lower urinary-tract symptoms (LUTS) and distinguish interstitial cystitis/bladder pain syndrome (IC/BPS) from other lower urinary-tract dysfunctions (LUTDs) through characteristic urinary biomarker levels. The results showed that urinary TNF-α and eotaxin levels can be used as biomarkers to differentiate IC/BPS from other LUTD subgroups in men with LUTS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Letter Oncology

Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium

Jiazheng Yu, Siyu Wu, Rong Li, Yuanhong Jiang, Jianyi Zheng, Zeyu Li, Mingyang Li, Kerong Xin, Xiaojiao Guan, Shijie Li, Xiaonan Chen

Summary: Antibody-drug conjugates (ADCs) combine the cytotoxicity of small-molecule drugs with antibody targeting and have become a new hotspot in the research and development of anti-tumor antibody drugs. This article summarizes impressive advancements in new clinical trials and clinical data on ADCs for the treatment of urothelial carcinoma at the 2023 ASCO-GU Cancers Symposium.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Letter Oncology

Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium

Yuanhong Jiang, Siyu Wu, Rong Li, Jiazheng Yu, Jianyi Zheng, Zeyu Li, Mingyang Li, Kerong Xin, Zhenqun Xu, Shijie Li, Xiaonan Chen

Summary: Numerous novel therapeutic agents and clinical trials for castration-resistant prostate cancer (CRPC) were presented at the 2023 ASCO-GU Cancers Symposium. Radionuclide drug conjugates (RDC), specifically 177Lu/111In-J591 and 225Ac-J591, showed improved efficacy in treating CRPC patients. Other promising approaches included dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors, PSCA-directed CAR-T cell immunotherapy, and AKTi-CAPltello-280 protein kinase inhibitor. We have summarized the latest CRPC treatment strategies and clinical trial advancements from the 2023 ASCO-GU Cancers Symposium.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)

Meeting Abstract Urology & Nephrology

THE REAL-LIFE PRACTICE OF INTRAVESICAL BOTULINUM TOXIN A INJECTION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME - SATISFACTION RATE AND PREDICTIVE FACTORS

Wei-Hsin Chen, Wan-Ru Yu, Jia-Fong Jhang, Yuan-Hong Jiang, Hann-Chorng Kuo

JOURNAL OF UROLOGY (2023)

Article Mathematics, Applied

VISION GRAPH U-NET: GEOMETRIC LEARNING ENHANCED ENCODER FOR MEDICAL IMAGE SEGMENTATION AND RESTORATION

Yuanhong Jiang, Qiaoqiao Ding, Yu Guang Wang, Pietro Lio, Xiaoqun Zhang

Summary: This paper proposes a new backbone neural network called vision graph U-Net (VGU-Net), which constructs multi-scale graph structures to extract long-range self-similarity information in images. By replacing CNNs with graph convolution networks, it allows an interpretation of long-range interactions. The VGU-Net achieves remarkable performance in reconstruction and segmentation tasks.

INVERSE PROBLEMS AND IMAGING (2023)

暂无数据